Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Screening for genetic disorders: need to avoid anxiety

16.12.2004


People screened for genetic disorders must have appropriate follow-up and monitoring to avoid stress and anxiety, according to new research sponsored by the ESRC.

Those with a condition may also find it difficult to have their disease diagnosed and treated satisfactorily, and there can be surprisingly little or no access to genetic counselling. These are among the key issues identified in a unique three-year project led by Professor Paul Atkinson of Cardiff University, examining the consequences of genetic screening. It calls for urgent attention to these issues from health policymakers and planners.

Focusing on the disorder Genetic Haemochromatosis, the research team followed up otherwise healthy blood donors whose blood was tested as part of a study by Cardiff haematologists, and who were identified as susceptible to the disorder. Haemochromatosis causes the body to absorb an excessive amount of iron from food, and this can lead to damage to the liver and other body tissues.



The research found that identifying individuals as being at risk does not automatically mean that other potentially vulnerable members of the family will be alerted. People picked out as being at risk, but who did not yet have any symptoms, were not unduly anxious about their health, provided they felt they were being monitored and looked after. As a result, they often did not feel the need to pass on information about the condition to blood relatives who might also be at risk.

The study reveals that the risk status of individuals can be fraught with uncertainty. Identifying the gene does not predict with any degree of certainty whether full-blown symptoms will ever develop or, if they do, their severity or timing of onset. Professor Atkinson said: “Since the genetic science is still in its infancy, population screening exposes people to tentative projections of risk without giving them anything definite to go on.”

Screening for individuals who are at risk results in simple forms of medical management of the condition, including periodic bleeding to reduce the overload of iron. But there may be a more complex and expensive consequence for health services if such people need continuing support and advice. Professor Atkinson said: “Population screening can create a considerable burden of counselling and follow-up for primary and secondary health care services.” He warned that as population screening becomes available for an increasing variety of medical conditions, this burden will have to be assessed and costed very carefully. “The costs will be considerable, and may not be the best use of resources, which may be better directed to good diagnosis of the clinical condition”, he said.
Researchers also interviewed people with full-blown clinical Haemochromatosis, and members of the Haemochromatosis Society, which provides support and information for those affected by the disorder.

They found that, in contrast to the screened individuals, people with the symptoms of the condition had often experienced considerable difficulty in receiving an accurate diagnosis and suitable treatment from their general practitioner.

Professor Atkinson added: “There is a clear need for better diagnosis for those who develop the clinical symptoms who, if untreated, can suffer serious damage to their health. Because Genetic Haemochromatosis is relatively uncommon, GPs are not necessarily well equipped to recognise the symptoms of the disease for what they are.”

Becky Gammon | alfa
Further information:
http://www.esrc.ac.uk

More articles from Health and Medicine:

nachricht Bioinspired nanoscale drug delivery method developed by WSU, PNNL researchers
10.01.2019 | Washington State University

nachricht How herpesviruses shape the immune system
09.01.2019 | German Center for Infection Research

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultra ultrasound to transform new tech

World first experiments on sensor that may revolutionise everything from medical devices to unmanned vehicles

The new sensor - capable of detecting vibrations of living cells - may revolutionise everything from medical devices to unmanned vehicles.

Im Focus: Flying Optical Cats for Quantum Communication

Dead and alive at the same time? Researchers at the Max Planck Institute of Quantum Optics have implemented Erwin Schrödinger’s paradoxical gedanken experiment employing an entangled atom-light state.

In 1935 Erwin Schrödinger formulated a thought experiment designed to capture the paradoxical nature of quantum physics. The crucial element of this gedanken...

Im Focus: Nanocellulose for novel implants: Ears from the 3D-printer

Cellulose obtained from wood has amazing material properties. Empa researchers are now equipping the biodegradable material with additional functionalities to produce implants for cartilage diseases using 3D printing.

It all starts with an ear. Empa researcher Michael Hausmann removes the object shaped like a human ear from the 3D printer and explains:

Im Focus: Elucidating the Atomic Mechanism of Superlubricity

The phenomenon of so-called superlubricity is known, but so far the explanation at the atomic level has been missing: for example, how does extremely low friction occur in bearings? Researchers from the Fraunhofer Institutes IWM and IWS jointly deciphered a universal mechanism of superlubricity for certain diamond-like carbon layers in combination with organic lubricants. Based on this knowledge, it is now possible to formulate design rules for supra lubricating layer-lubricant combinations. The results are presented in an article in Nature Communications, volume 10.

One of the most important prerequisites for sustainable and environmentally friendly mobility is minimizing friction. Research and industry have been dedicated...

Im Focus: Mission completed – EU partners successfully test new technologies for space robots in Morocco

Just in time for Christmas, a Mars-analogue mission in Morocco, coordinated by the Robotics Innovation Center of the German Research Center for Artificial Intelligence (DFKI) as part of the SRC project FACILITATORS, has been successfully completed. SRC, the Strategic Research Cluster on Space Robotics Technologies, is a program of the European Union to support research and development in space technologies. From mid-November to mid-December 2018, a team of more than 30 scientists from 11 countries tested technologies for future exploration of Mars and Moon in the desert of the Maghreb state.

Close to the border with Algeria, the Erfoud region in Morocco – known to tourists for its impressive sand dunes – offered ideal conditions for the four-week...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Our digital society in 2040

16.01.2019 | Event News

11th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Aachen, 3-4 April 2019

14.01.2019 | Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

 
Latest News

Brilliant glow of paint-on semiconductors comes from ornate quantum physics

17.01.2019 | Materials Sciences

Drones shown to make traffic crash site assessments safer, faster and more accurate

17.01.2019 | Information Technology

Ultra ultrasound to transform new tech

17.01.2019 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>